| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.5 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.13 | 0.5 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |